• Home
  • Shop
  • About
  • FAQ
  • Contact
  • Compare Peptides
  • Wholesale
  • Home Shop Hormonal Research Peptides Tesamorelin
    Tesamorelin-10mg

    Tesamorelin

    $65.00
    ● In Stock — Ships within 24 hours

    Tesamorelin (10mg) is a research grade, 44-amino acid synthetic analog of human growth hormone-releasing hormone (GHRH 1-44), supplied as a lyophilized powder at ≥99% purity (HPLC verified). This peptide features an N-terminal trans-3-hexenoic acid modification and is widely referenced in peer-reviewed literature investigating the growth hormone axis. For research use only.

    🏷 The more you buy, the more you save
    QtyPrice per vialSavings
    1 – 3$65.00
    4 – 5$58.50 Save 10%
    6 – 7$55.25 Save 15%
    8 – 10$52.00 Save 20%
    11 – 19$48.75 Save 25%
    20+$45.50 Save 30%
    💧 Need reconstitution solution? Add Bacteriostatic Water ($29) to your order.
    🔒 Secure Bank Payment✅ 99%+ Purity Verified🚚 Ships in 24 Hours

    Product Description

    Tesamorelin — Stabilized GHRH Analog Research Peptide (10mg / 20mg)

    Tesamorelin (TH9507) is a stabilized synthetic analog of growth-hormone-releasing hormone (GHRH), one of the most clinically characterized GHRH analogs in the research literature. Its N-terminal trans-3-hexenoyl modification confers resistance to enzymatic degradation, making it a robust tool for studying GHRH-receptor signaling and the somatotropic axis. Available in 10mg and 20mg sizes; select your research format above. Purity ≥98%, verified by HPLC and mass spectrometry.

    Research Specifications

    CompoundTesamorelin (TH9507)
    CAS Number218949-48-5
    Molecular FormulaC221H366N72O67S
    Molecular Weight5135.9 g/mol
    PubChem CID16137828
    SequenceTrans-3-hexenoyl-modified GHRH(1-44) analog (44 amino acids)
    Reported Half-Life~26–38 minutes in published pharmacokinetic reports
    Purity≥98% (HPLC / MS verified)
    AppearanceWhite lyophilized powder
    SolubilitySoluble in bacteriostatic or sterile water
    FormLyophilized powder for reconstitution

    Mechanism of Action

    Tesamorelin binds the GHRH receptor on pituitary somatotrophs, stimulating endogenous synthesis and pulsatile release of growth hormone (GH) through cAMP/PKA signaling.

    Stabilized GHRH Backbone

    The trans-3-hexenoyl group at the N-terminus protects tesamorelin from rapid enzymatic breakdown, extending its functional window relative to native GHRH(1-44) in research settings.

    Somatotropic-Axis Research

    Because it stimulates the body's own GH release rather than supplying exogenous GH, tesamorelin is a valuable tool for studying physiological GH-axis regulation and feedback.

    Visceral-Adipose Signaling

    Tesamorelin is notable in the literature for research into GH-axis effects on visceral adipose tissue.

    Research Applications

    GH-Axis Research

    Used to study GHRH-receptor signaling and pulsatile GH release in preclinical models.

    Metabolic & Adipose Research

    Investigated for GH-axis effects on visceral fat metabolism.

    Comparative GHRH Pharmacology

    Studied alongside GHRH analogs such as CJC-1295 to compare stability and signaling.

    Published Research Studies

    1. Falutz J, et al. (2007) – tesamorelin research
    Published clinical research characterizing tesamorelin's GH-axis and visceral-adipose effects. (PMID: 18184952)

    Reconstitution and Handling in Research

    The following summarizes standard laboratory handling for lyophilized research peptides. This product is intended for research use only and is not for human consumption.

    Reconstitute the lyophilized powder by adding bacteriostatic or sterile water down the inside wall of the vial using a sterile syringe. Gently swirl to dissolve—do not shake, as agitation can shear peptide structure. The solvent volume selected determines the working concentration for a given research protocol. For step-by-step technique and dilution calculations, see our peptide reconstitution guide and pair with bacteriostatic water.

    Storage and Handling

    Lyophilized (unreconstituted): Store at -20°C for long-term stability (up to 24 months) or at 2–8°C for shorter periods, protected from light and moisture. Avoid repeated freeze-thaw cycles.

    Reconstituted: Store at 2–8°C and use within 4–6 weeks. For longer storage, aliquot into single-use volumes and freeze at -20°C. See our full peptide storage guide.

    Safety Profile in Research

    As with all research compounds, investigators should follow standard laboratory safety protocols, including appropriate personal protective equipment (PPE) when handling reconstituted solutions. Tesamorelin is for in-vitro and laboratory research use only and is not intended for human consumption, therapeutic use, or diagnostic purposes. A downloadable Research Product Safety Sheet is available in the Documentation & Research Resources section on this page.

    Frequently Asked Questions

    What sizes does Tesamorelin come in?

    Tesamorelin is available as a variable product in 10mg and 20mg vials. Use the size selector above to choose your research format.

    What is tesamorelin used for in research?

    Tesamorelin is used to study GHRH-receptor signaling, the somatotropic axis, and GH-axis metabolic effects in laboratory models. It is intended strictly for research use.

    What is the purity of Tesamorelin?

    Each batch is verified at ≥98% purity by HPLC and mass spectrometry.

    Why Buy Tesamorelin from Iron Peak Peptides?

    Every batch of Tesamorelin undergoes third-party analytical testing—HPLC, mass spectrometry, and endotoxin screening—to verify purity, identity, and composition, with batch-specific quality-assurance documentation included. Iron Peak Peptides maintains full traceability from raw material to finished vial, ships quickly with proper handling, and backs every order with responsive research support. When you choose IronPeak, you partner with a supplier that prioritizes scientific rigor and product quality above all else.

    References & Research Resources

    1. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-2370.
    2. PubChem Compound Summary: Tesamorelin (CID 16137828).
    3. Browse current Tesamorelin primary literature on PubMed

    Additional Information

    Size 10mg, 20mg